Hitachi to Showcase Cutting-Edge Solutions at the Cell & Gene Meeting on the Mesa 2025

Hitachi's Commitment to Cell and Gene Therapy Innovation

Hitachi Ltd. is set to make a significant impact as a Gold Sponsor at the Cell & Gene Meeting on the Mesa scheduled for October 6-8, 2025, in Phoenix, Arizona. This prestigious event stands as one of the premier annual international conferences within the fields of cell and gene therapy. It gathers top executives and decision-makers from the industry to engage in comprehensive discussions ranging from groundbreaking research findings to tackling challenges in commercializing innovative therapies.

At this influential event, Hitachi will showcase its advanced solutions that integrate measuring technologies, AI, and automation. These offerings are meticulously designed for the cell and gene therapy sector, underscoring Hitachi’s strong commitment to advancing health care through digital innovation.

Focus on Growth in Biopharmaceuticals

Hitachi has strategically positioned biopharmaceuticals and gene-cell therapy as pivotal growth areas. The company is keen on enhancing its global presence in drug discovery and manufacturing processes by digitalizing and streamlining operations. As part of this initiative, Hitachi aims to leverage collaborations with global partners to contribute to the clinical and commercial advancement of new treatment methodologies, thereby improving overall well-being for people worldwide.

With an extensive data repository from its established product installations in the domain of healthcare, Hitachi plans to propel its Lumada 3.0 initiative. This progressive approach combines domain knowledge with AI analytics to address pressing issues faced by customers and society at large.

Featured Solutions at the Conference

Hitachi will introduce an array of innovative products and solutions tailored for the regenerative medicine market, including:
1. iACE2 (ACC-200) Automated Cell Culture System - A state-of-the-art device designed for efficient cell culture automation.
2. Regenerative Medicine Facility Solutions - Comprehensive services and infrastructure for regenerative medicine applications.
3. Next-Generation Modular CPC (Cell Culture Processing Facility) - A modern facility that adapts to various processing needs in cell culture.
4. Hitachi Value Chain Traceability Service for Regenerative Medicine - An integrated platform ensuring the management of the product value chain in regenerative medicine.
5. HITPHAMS for Pharmaceutical and Medical Device Manufacturing - A robust manufacturing and quality management system exclusive to Hitachi in Japan.

These solutions epitomize Hitachi's innovative approach to merge digital and biotechnological advancements, thus facilitating the effective development of cell and gene therapies.

About the Event: Cell & Gene Meeting on the Mesa

Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a distinguished international conference focused on the regenerative medicine and cell/gene therapy sectors. The event brings together key stakeholders from pharmaceutical companies, biotechnology firms, academic institutions, investors, and regulatory authorities. Its primary aim is to foster discussions on the latest technologies and market trends while strengthening partnerships within the industry.

For more information, you can visit the official website at Cell & Gene Meeting on the Mesa.